Product NDC: | 0378-4093 |
Proprietary Name: | Ropinirole Hydrochloride |
Non Proprietary Name: | ropinirole hydrochloride |
Active Ingredient(s): | 8 mg/1 & nbsp; ropinirole hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-4093 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200462 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121016 |
Package NDC: | 0378-4093-05 |
Package Description: | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4093-05) |
NDC Code | 0378-4093-05 |
Proprietary Name | Ropinirole Hydrochloride |
Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0378-4093-05) |
Product NDC | 0378-4093 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ropinirole hydrochloride |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20121016 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | ROPINIROLE HYDROCHLORIDE |
Strength Number | 8 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |